Recent RMD News
- ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024 • GlobeNewswire Inc. • 04/25/2024 08:05:00 PM
- ResMed to Report Third Quarter Fiscal 2024 Earnings on April 25, 2024 • GlobeNewswire Inc. • 04/04/2024 08:05:00 PM
- ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis • GlobeNewswire Inc. • 03/15/2024 07:05:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 01:46:43 AM
- Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Performance of ResMed’s Smallest Full-Face CPAP Mask • GlobeNewswire Inc. • 03/06/2024 02:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 12:11:51 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 10:55:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/01/2024 10:08:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 11:40:35 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/23/2024 02:41:49 AM
- ResMed’s New AirCurve™ 11 Bilevel Devices Enable Healthcare Providers to Make Informed Decisions about Care, Deliver Personalized Support, and Drive Positive Therapy Outcomes for Patients with Sleep Apnea • GlobeNewswire Inc. • 02/12/2024 09:16:33 PM
- MatrixCare Earns Three 2024 Best in KLAS Awards • GlobeNewswire Inc. • 02/07/2024 01:05:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/06/2024 04:21:45 PM
- Philips Shares Drop 6% as US Sales Halted Following Agreement on Faulty Sleep Apnea Devices, and more Wall Street Highlights • IH Market News • 01/29/2024 11:09:38 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/25/2024 06:48:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/24/2024 09:06:01 PM
- ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2024 • GlobeNewswire Inc. • 01/24/2024 09:05:00 PM
- ResMed to Report Second Quarter Fiscal 2024 Earnings on January 24, 2024 • GlobeNewswire Inc. • 01/03/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 08:20:12 PM
- ResMed Announces Participation in the 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 12/27/2023 09:05:00 PM
- ResMed Notifies Customers About Updated Instructions and Labeling for Masks with Magnets Due to Potential Interference with Certain Medical Devices • GlobeNewswire Inc. • 12/20/2023 09:05:00 PM
- ResMed Secures Significant Victory in Patent Fight Against New York University • GlobeNewswire Inc. • 12/11/2023 09:05:00 PM
- Study Estimates a 23% Increase in COPD by 2050, Representing 600 Million Patients Globally • GlobeNewswire Inc. • 12/07/2023 08:34:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/30/2023 12:45:21 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM